A novel approach to removing excess fluid through the skin and a new strategy to prevent right ventricular failure after LVAD implantation are among the highlights of the January issue of the Journal ...

Background Aortic stenosis (AS) frequently coexists with heart failure (HF), but its prevalence, prognostic impact and ...

Cutting-edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). Heart Failure is the ...

Counterpart Health, Inc., a subsidiary of Clover Health, released research indicating that its AI-powered platform, Counterpart Assistant (CA), significantly improves the management of congestive ...

Panelists discuss how quality metrics should focus on keeping patients out of hospitals through core medical therapies, measuring all-cause hospitalizations and days spent at home in the community, ...

Nearly 6.7 million adults in the U.S. have heart failure, with prevalence expected to rise to 8.5 million by 20301,2. While heart failure is a chronic, progressive disease, advances in technology are ...

NEW YORK (Reuters) - The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell ...

DUBLIN--(BUSINESS WIRE)--FIRE1, a leading connected medical device solutions company, today announced the successful completion of a $120 million financing round to accelerate the company’s mission to ...

The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...